Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo
Cart
header search
Search
Skip Nav Destination

Written in Blood

Research from recent issues of Blood
Caplacizumab Improves ADAMTS13 Recovery in Patients with iTTP
Lara C. Pullen, PhD
March 21, 2024
High-Dose Oral Vitamin A Before HCT May Reduce GVHD in Children
Katie Robinson
March 21, 2024
Elevated White Blood Cell Counts, Hematocrit Levels Linked to Thrombotic Events in Polycythemia Vera
Lara C. Pullen, PhD
March 21, 2024
Unique Molecular Subtypes within BCR::ABL1-Postive ALL Show Prognostic Relevance
Khylia Marshall
February 20, 2024
CD20 Loss a Cause of Mosunetuzumab Resistance in Non-Hodgkin Lymphoma
Ruth Jessen Hickman, MD
February 20, 2024
In the Long Run, Ibrutinib Brings Disease Control, but Cardiac Risks, in Older Patients with Untreated CLL
Thomas R. Collins
February 20, 2024
Detection of Persistent Free Light Chain Using Mass Spectrometry Is a Sensitive Marker of OS in AL Amyloidosis
Anna Azvolinsky, PhD
February 20, 2024
Survival in Primary Hemophagocytic Lymphohistiocytosis Can Be as High as 100%
Lara C. Pullen, PhD
January 23, 2024
Anti-PF4 Immunothrombosis Absent Proximate Heparin or Adenovirus Vector Vaccine Exposure
Lara C. Pullen, PhD
January 23, 2024
Time-Limited Ibrutinib, CD19-Directed CAR-T Combo Shows Efficacy for Poor-Risk, R/R Mantle Cell Lymphoma
Khylia Marshall
January 23, 2024
Inotuzumab as a Bridging Therapy to Eradicate MRD Improves OS in Patients With ALL
Khylia Marshall
January 23, 2024
Serum TARC Levels Increased Years Prior to Hodgkin Lymphoma Diagnosis
Leah Lawrence
January 9, 2024
Real-World Studies Show Poorer Outcomes for Tafasitamab, Lenalidomide in R/R LBCL
Ruth Jessen Hickman, MD
November 30, 2023
Study Validates Surrogate Markers for EMZL Therapy, Shortens Future Trial Duration
Khylia Marshall
November 30, 2023
Biomarkers Related to VTE Risk Decrease Within Weeks of Stopping Combined Hormonal Contraception
Anna Azvolinsky, PhD
November 30, 2023
Study Characterizes Rare Genetic Platelet Disorder Associated with Blood Cancers
Deborah Levenson
November 30, 2023
TP53 Status May Hint at Acute Myeloid Leukemia Prognosis
Lara C. Pullen, PhD
November 14, 2023
No Change in Platelet Count Threshold of Patients With ITP Treated With Aspirin
Khylia Marshall
November 14, 2023
Children With T-ALL Show Similar Treatment Outcomes Independent of ETP Status
Katie Robinson
October 31, 2023
Study Suggests Iron Homeostasis Is Key in Pregnancy Outcomes in Thalassemic Mice
Thomas R. Collins
October 31, 2023

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
May 2025

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals